Literature DB >> 7370159

In vitro chemosensitivity tests on xenografted human melanomas.

A E Bateman, P J Selby, G G Steel, G D Towse.   

Abstract

An in vitro chemosensitivity test has been applied to malignant melanoma cells from 5 patients. The tumour cells were first grown as xenografts in immune-suppressed mice, so that the results of the in vitro test could be compared with precise measurements of the sensitivity of the melanoma cells when exposed to chemotherapeutic drugs in vivo in the mouse. The in vitro assay involved exposing the tumour cells to each of 8 drugs, after which cell survival was determined by colony assay in soft agar. Dose-response curves were obtained and the surviving fraction at drug levels estimated to be achieved in man was used as a measure of in vitro drug sensitivity. Significant differences among the 8 drugs were detected, and these accorded with clinical experience. The correlation of in vivo (in the mouse) and in vitro sensitivities to Melphalan and MeCCNU was also significant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370159      PMCID: PMC2010210          DOI: 10.1038/bjc.1980.29

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Chemotherapy of human colon cancer xenografts in athymic nude mice.

Authors:  R Osieka; D P Houchens; A Goldin; R K Johnson
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

2.  High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.

Authors:  T J McElwain; D W Hedley; M Y Gordon; M Jarman; J L Millar; J Pritchard
Journal:  Exp Hematol       Date:  1979       Impact factor: 3.084

3.  Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (Me CCNU) in man.

Authors:  R W Sponzo; V T DeVita; V T Oliverio
Journal:  Cancer       Date:  1973-05       Impact factor: 6.860

4.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.

Authors:  V D Courtenay; J Mills
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

5.  Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.

Authors:  K Nowak; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

6.  Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour.

Authors:  A E Bateman; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

7.  Improved immune-suppression techniques for the exongrafting of human tumours.

Authors:  G G Steel; V D Courtenay; A Y Rostom
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

8.  Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation.

Authors:  P J Selby; J M Thomas; P Monaghan; J Sloane; M J Peckham
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

9.  A colony-forming assay for human tumour xenografts using agar in diffusion chambers.

Authors:  I E Smith; V D Courtenay; M Y Gordon
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

10.  Evaluation of single-agent therapy in human colorectal tumour xenografts.

Authors:  P J Houghton; J A Houghton
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

  10 in total
  11 in total

Review 1.  Predictive testing in cancer chemotherapy. II. In vitro.

Authors:  P H Slee; A T Van Oosterom; E A De Bruijn
Journal:  Pharm Weekbl Sci       Date:  1985-08-23

Review 2.  Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients.

Authors:  P J Selby; D Raghavan
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

3.  Experimental correlations of in vitro drug sensitivity with in vivo responses to ThioTEPA in a panel of murine colon tumours.

Authors:  R M Phillips; M C Bibby; J A Double
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Variations in exposure to mitomycin C in an in vitro colony-forming assay.

Authors:  P H Slee; E A de Bruijn; P Leeflang; P J Kuppen; L van den Berg; A T van Oosterom
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

5.  The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts.

Authors:  V D Courtenay; J Mills; G G Steel
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

6.  Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.

Authors:  G H Boerrigter; E C Heinerman; B J Braakhuis; G B Snow
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

Review 7.  The response to chemotherapy of a variety of human tumour xenografts.

Authors:  G G Steel; V D Courtenay; M J Peckham
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

8.  Quantitation of drug sensitivity by human metastatic melanoma colony-forming units.

Authors:  F L Meyskens; T E Moon; B Dana; E Gilmartin; W J Casey; H S Chen; D H Franks; L Young; S E Salmon
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

9.  Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy.

Authors:  P J Selby; V D Courtenay; T J McElwain; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

10.  Clonogenic cell survival in cryopreserved human tumour cells.

Authors:  P J Selby; G G Steel
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.